PAhR Therapeutics

PAhR Therapeutics is a clinical-stage company focused on developing novel mechanisms for the treatment of pulmonary arterial hypertension (PAH)

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical development

Model

01Company Overview

PAhR Therapeutics is a clinical-stage company focused on developing novel mechanisms for the treatment of pulmonary arterial hypertension (PAH).

02Backed By1 investor

03Similar Companies

G

Gossamer

Biotech & Life Sciences

→

CT

VP

VP

GT

04Startup DNA

6

signals

Sectors
Business Model
Technology